| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/04/2004 | DE10130155B3 Reportergen-Konstrukt zum Nachweis von HIV-Rev und HIV-Tat Reporter gene construct for the detection of HIV-Rev and HIV-Tat |
| 03/04/2004 | CA2746000A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745998A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745731A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745724A1 Biomarkers comprising peptide sequence vnhvtlsopk for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745569A1 Biomarkers for diagnosing alzheimer`s disease |
| 03/04/2004 | CA2536254A1 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | CA2499755A1 Fluorescent protein and chromoprotein |
| 03/04/2004 | CA2497107A1 Methods and compositions for categorizing patients |
| 03/04/2004 | CA2496984A1 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents |
| 03/04/2004 | CA2496952A1 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | CA2496781A1 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | CA2496750A1 Vaccine for respiratory and reproductive system infections in cattle |
| 03/04/2004 | CA2496732A1 Synthetic heparin-binding growth factor analogs |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496384A1 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/04/2004 | CA2496321A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/04/2004 | CA2496242A1 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | CA2496236A1 Preventives/remedies for cancer |
| 03/04/2004 | CA2495972A1 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 03/04/2004 | CA2495794A1 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | CA2495546A1 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | CA2495425A1 Method for screening the allelic state at the 5'-flanking region of the alfasi casein gene |
| 03/04/2004 | CA2495336A1 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/04/2004 | CA2494963A1 T-cell epitopes in erythropoietin |
| 03/04/2004 | CA2494806A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/04/2004 | CA2493471A1 Compounds binding to p-selectin |
| 03/04/2004 | CA2493333A1 Chimeric mhc protein and oligomer thereof |
| 03/03/2004 | EP1394549A1 Biomarkers for diagnosing Alzheimer's disease |
| 03/03/2004 | EP1394548A2 Method for serotyping using type-specific antigens |
| 03/03/2004 | EP1394543A1 Screening method |
| 03/03/2004 | EP1394542A1 Method of screening prion disease infection factor |
| 03/03/2004 | EP1394267A1 Single nucleotide polymorphisms predictive for cardiovascular disease, adverse drug reactions, and drug efficacy |
| 03/03/2004 | EP1394261A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 03/03/2004 | EP1394259A2 Recombinant infectious non-segmented negative strand RNA virus |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394254A1 Method of producing antigens, antigens and their use |
| 03/03/2004 | EP1394252A2 70 human secreted proteins |
| 03/03/2004 | EP1394184A1 Apoptose inhibitor |
| 03/03/2004 | EP1394181A1 DNA vaccine |
| 03/03/2004 | EP1394180A1 Synthetic mimetic molecules of physiological binding molecules |
| 03/03/2004 | EP1394179A1 Process for producing erythropoietin free from animal proteins |
| 03/03/2004 | EP1394178A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 03/03/2004 | EP1394177A1 High density lipoprotein-reactive peptides |
| 03/03/2004 | EP1394176A1 Novel mucin binding polypeptides derived from Lactobacillus johnsonii |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393744A1 Acellular pertussis vaccines and methods of preparation thereof |
| 03/03/2004 | EP1393235A1 Crystallized human xenobiotic nuclear receptor pxr/sxr ligand binding domain polypeptide and screening methods employing same |
| 03/03/2004 | EP1393077A2 Method for identifying ligands for g protein coupled receptors |
| 03/03/2004 | EP1393039A2 Mutation induced optimization of receptor signal to noise ratio |
| 03/03/2004 | EP1392865A2 Novel proteins and nucleic acids encoding same |
| 03/03/2004 | EP1392864A2 Compositions and methods for gender sorting |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392859A2 Isolating cells expressing secreted proteins |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 03/03/2004 | EP1392838A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 03/03/2004 | EP1392836A2 Specific promotor of the human vascular endothelial cadherin-2 (hve-cad-2) gene and the therapeutic uses thereof |
| 03/03/2004 | EP1392835A2 Expression vector using for animal cell |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392830A2 Interleukin-18 mutants, their production and use |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392826A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/03/2004 | EP1392821A1 Dna molecules encoding macaca mulatta androgen receptor |
| 03/03/2004 | EP1392820A1 Cyp450-specific dna probes and primers, and biological applications thereof |
| 03/03/2004 | EP1392818A1 Chimeric immunoreceptor useful in treating human cancers |
| 03/03/2004 | EP1392817A2 Human secreted proteins |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392732A2 Method for apo ciii measurement in apob and non apob containing particles |
| 03/03/2004 | EP1392731A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 03/03/2004 | EP1392730A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent |
| 03/03/2004 | EP1392729A2 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhalation devices and method of diagnosis |
| 03/03/2004 | EP1392728A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 03/03/2004 | EP1392727A1 Production of a stress protein |
| 03/03/2004 | EP1392726A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 03/03/2004 | EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 03/03/2004 | EP1392724A2 G-protein coupled receptor |
| 03/03/2004 | EP1392723A2 Medane genes and proteins |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1392716A1 Isolated human secreted proteins nucleic acid molecules encoding human secreted proteins and uses thereof |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392358A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 03/03/2004 | EP1392357A2 Vaccine composition |
| 03/03/2004 | EP1392356A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392350A2 Optimization of the molecular properties and formulation of proteins delivered by inhalation |
| 03/03/2004 | EP1392346A2 Composition and method for enhancing elasticity of tissue |
| 03/03/2004 | EP1392344A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor |
| 03/03/2004 | EP1392343A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 03/03/2004 | EP1392342A1 Global analysis of protein activities using proteome chips |
| 03/03/2004 | EP1392341A2 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof |
| 03/03/2004 | EP1392340A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |